Abstract:BACKGROUND Gastric cancer (GC) is one of the most common and deadliest types of cancer worldwide due to its delayed diagnosis and high metastatic frequency, but its exact pathogenesis has not been fully elucidated. ETS homologous factor (EHF) is an important member of the ETS family and contributes to the pathogenesis of multiple malignant tumors. To date, whether EHF participates in the development of GC via the c-Met signaling pathway remains unclear. AIM To investigate the role and mechanism of EHF in the occurrence and development of GC. METHODS The expression of EHF mRNA in GC tissues and cell lines was measured by quantitative PCR. Western blotting was performed to determine the protein expression of EHF, c-Met, and its downstream signal molecules. The EHF expression in GC tissues was further detected by immunohistochemical staining. To investigate the role of EHF in GC oncogenesis, small interfering RNA (siRNA) against EHF was transfected into GC cells. The cell proliferation of GC cells was determined by Cell Counting Kit-8 and colony formation assays. Flow cytometry was performed following Annexin V/propidium iodide (PI) to identify apoptotic cells and PI staining to analyze the cell cycle. Cell migration and invasion were assessed by transwell assays. RESULTS The data showed that EHF was upregulated in GC tissues and cell lines in which increased expression of c-Met was also observed. Silencing of EHF by siRNA reduced the proliferation of GC cells. Inhibition of EHF induced significant apoptosis and cell cycle arrest in GC cells. Cell migration and invasion were significantly inhibited. EHF silencing led to c-Met downregulation and further blocked the Ras/c-Raf/extracellular signal-related kinase 1/2 (Erk1/2) pathway. Additionally, phosphatase and tensin homolog was upregulated and glycogen synthase kinase 3 beta was deactivated. Moreover, inactivation of signal transducer and activator of transcription 3 was detected following EHF inhibition, leading to inhibition of the epithelial-to-mesenchymal transition (EMT). CONCLUSION These results suggest that EHF plays a key role in cell proliferation, invasion, apoptosis, the cell cycle and EMT via the c-Met pathway. Therefore, EHF may serve as an antineoplastic target for the diagnosis and treatment of GC.

Expression and Clinical Significance of ECHS1 in Gastric Cancer.

Blockage of ETS Homologous Factor Inhibits the Proliferation and Invasion of Gastric Cancer Cells Through the C-Met Pathway

Identification of Significant Biomarkers and Pathways Associated with Gastric Carcinogenesis by Whole Genome-Wide Expression Profiling Analysis

Overexpression of Endothelial Cell Specific Molecule-1 (ESM-1) in Gastric Cancer

ESM1 facilitates the EGFR/HER3-triggered epithelial-to-mesenchymal transition and progression of gastric cancer via modulating interplay between Akt and angiopoietin-2 signaling

Novel Potential Therapeutic Target for E2F1 and Prognostic Factors of E2F1/2/3/5/7/8 in Human Gastric Cancer.

[Alteration of Early Growth Response 1 Expression in Gastroenterological Cancers and Its Biological Significance].

Differential Expression of COL6 Family is a Potential Tumor Marker for Predicting Gastric Cancer

Abnormal Expression of Early Growth Response 1 in Gastric Cancer: Association with Tumor Invasion, Metastasis and Heparanase Transcription

Translation Elongation Factor Eef1bα is Identified As a Novel Prognostic Marker of Gastric Cancer

Euchromatic Histone Lysine Methyltransferase 1 Regulates Cancer Development in Human Gastric Cancer by Regulating E-cadherin

Association Between EphA1 and Tumor Microenvironment in Gastric Carcinoma and its Clinical Significance

Ets1 As a Marker of Malignant Potential in Gastric Carcinoma.

Identification and validation of biomarkers for epithelial-mesenchymal transition-related cells to estimate the prognosis and immune microenvironment in primary gastric cancer by the integrated analysis of single-cell and bulk RNA sequencing data

High expression of oncogene cadherin-6 correlates with tumor progression and a poor prognosis in gastric cancer

[Relationship Between Ets-1 Expression and Angiogenesis, Clinicopathological Features and Survival of Patients with Gastric Carcinoma].

EFHD1 Expression is Correlated with Tumor-Infiltrating Neutrophils and Predicts Prognosis in Gastric Cancer

ETS1-Mediated Control of EFNA4 in Gastric Cancer: Effects on Epithelial-Mesenchymal Transition and Cancer Immune Response

Overexpression of Lymphocyte Antigen 6 Complex, Locus E in Gastric Cancer Promotes Cancer Cell Growth and Metastasis

Expression and Clinical Significance of Autophagic Protein LC3B and EMT Markers in Gastric Cancer

Abnormal Expression of E-Cadherin in Tumor Cells is Associated with Poor Prognosis of Gastric Carcinoma